SIBP-03

· Shanghai Institute Of Biological Products

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SIBP-03, covering 2026-01-16 to 2026-01-16. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial of SIBP-03 in Patients With Head and Neck Squamous Cell Carcinoma [Phase 2]